Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 76,015 | N/A | N/A |
| Marketable Securities | 15,942 | N/A | N/A |
| TOTAL | $92,845 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 3,794 | N/A | N/A |
| Other Non-Current Assets | 20,063 | 0 | 0 |
| TOTAL | $23,857 | $N/A | $N/A |
| Total Assets | $116,702 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 3,276 | 0 | 0 |
| Accrued Expenses | 4,568 | N/A | N/A |
| TOTAL | $34,570 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 23,349 | N/A | N/A |
| Other Non-Current Liabilities | 16,651 | 0 | 0 |
| TOTAL | $47,458 | $N/A | $N/A |
| Total Liabilities | $82,028 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -76,456 | N/A | N/A |
| Other shareholders' equity | 109,086 | 0 | 0 |
| TOTAL | $34,674 | $N/A | $N/A |
| Total Liabilities And Equity | $116,702 | $0 | $0 |